Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) in Egypt
Bioventure Bioventure logo Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership…
Bioventure Bioventure logo Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership…
– Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership between Alvotech…
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenous Tecentriq,…
NAPLES, Fla., Aug. 29, 2023 (GLOBE NEWSWIRE) — Intetics, a leading American technology company, introduces…
CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC announced it acted as sole lead arranger and administrative agent on…
Fourth quarter sales declined 1.2% compared with fiscal 2022; full-year sales increased 3.8% Fourth quarter…
NEW ORLEANS–(BUSINESS WIRE)–Barrell Energy, Inc. announces the development of the Gulf Coast Storage Network. Barrell…
New solution empowers enterprises to achieve sustainability goals through a lower-carbon emissions alternative to transport…
Company Anticipates Read Outs of the Clinical Data from its EU and US Feasibility Studies…
“In the second quarter of 2023, Mendus’ main objectives were focused on driving the evolution…
Saint–Herblain (France), August 29, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
Evrysdi available to treat people of all ages with SMA in the European Union, including…
Stange Law Firm, a trusted leader in family law and divorce legal services, announces the…
KUCHING, MALAYSIA, Aug 29, 2023 – (ACN Newswire) – Industrialised building systems specialist, Sarawak Consolidated…
PETALING JAYA, Malaysia, Aug 29, 2023 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad,…
61% of executives are confident that AI will help their companies reach their objectives –…
This partnership allows financial market participants to incorporate ESG and impact considerations into their investment…
Summary Highlights (including post-period events) The US Food and Drug Administration (FDA) granted bexmarilimab Orphan Drug Designation…
ODD further strengthens bexmarilimab program by offering clinical development and commercialization benefits Expected completion of…
MORRISTOWN, N.J.–(BUSINESS WIRE)–Avaya, a global leader in customer experience solutions, today announced eight North American…